• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. MERIDIAN FILTER SYSTEM ¿ FEMORAL; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. MERIDIAN FILTER SYSTEM ¿ FEMORAL; VENA CAVA FILTER Back to Search Results
Catalog Number MD800F
Device Problems Difficult to Remove (1528); Patient-Device Incompatibility (2682); Detachment of Device or Device Component (2907); Patient Device Interaction Problem (4001)
Patient Problems Abdominal Pain (1685); Chest Pain (1776); Cardiac Tamponade (2226); Cardiac Perforation (2513); Foreign Body In Patient (2687); Device Embedded In Tissue or Plaque (3165); Pericardial Effusion (3271)
Event Date 10/12/2017
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: a lot history review was performed.This is the only complaint to date for this lot number.Therefore, a device history record (dhr) review is not required.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately five years and four months post filter deployment, the patient presented with pericardial effusion and scheduled for the inferior vena cava filter retrieval.The filter was fractured with one locally retained arm in the ivc and two arms in the right ventricle.The filter was then dissected free of the ivc wall using endobronchial forceps in the jaws of life technique and it was removed successfully.Next the locally retained fragment was also removed using forceps.Then, attention was directed to the fractured fragments in the right ventricle.Subsequently, ventriculogram revealed, two filter struts in the antero inferior right ventricle.Multiple attempts were made to remove the foreign bodies with snares was unsuccessful.The filter was inspected and found to be removed in its entirely.Subsequent computer tomography revealed, inferior vena cava filter strut was imbedded in the apex of the rv septum.Therefore, the investigation is confirmed for the filter limb detachment.However, the investigation is inconclusive for the perforation of the ivc and retrieval difficulties.Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.Expiry date: (05/2013).
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient in conjunction with or before bariatric procedure.At some time post filter deployment, it was alleged that the filter struts were detached, perforated beyond the lumen of the inferior vena cava and embolized within the right ventricle.The device was removed percutaneously through complex filter removal using the jaws of life technique.The detached strut retained in right ventricle free wall was removed via an open chest procedure after an unsuccessful open chest procedural attempt.The current status of the patient is unknown.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient in conjunction with or before bariatric procedure.At some time post filter deployment, it was alleged that the filter struts were detached, perforated beyond the lumen of the inferior vena cava and embolized within the right ventricle.It was further reported that the health care provider was able to remove the filter and the fractured strut from the inferior vena cava (ivc) wall by jaw of life technique and forceps.After an unsuccessful attempt to remove two struts from right ventricle (rv) via snare, one strut removed from the rv wall, however, one strut remained in the apex of the septum.The current status of the patient is unknown.
 
Manufacturer Narrative
H10: manufacturing review: a lot history review was performed.This is the only complaint to date for this lot number.Therefore, a device history record (dhr) review is not required.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately five years and four months post filter deployment, the patient presented with pericardial effusion and scheduled for the inferior vena cava filter retrieval.The filter was fractured with one locally retained arm in the ivc and two arms in the right ventricle.The filter was then dissected free of the ivc wall using endobronchial forceps in the jaws of life technique and it was removed successfully.Next the locally retained fragment was also removed using forceps.Then, attention was directed to the fractured fragments in the right ventricle.Subsequently, ventriculogram revealed, two filter struts in the antero inferior right ventricle.Multiple attempts were made to remove the foreign bodies with snares was unsuccessful.The filter was inspected and found to be removed in its entirely.Subsequent computer tomography revealed, inferior vena cava filter strut was imbedded in the apex of the rv septum.Therefore, the investigation is confirmed for the filter limb detachment.However, the investigation is inconclusive for the perforation of the ivc and retrieval difficulties.Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.H10: b5, d4(expiry date: 05/2013).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient in conjunction with or before bariatric procedure.At some time post filter deployment, it was alleged that the filter struts detached, nine filter struts extended inferiorly from the filter apex and perforated beyond the lumen of the ivc, including struts abutting the undersurface of the duodenum, the lateral aspect of the aorta, and the anterior aspect of the vertebral bodies.The device was removed percutaneously through complex filter removal using the jaws of life technique.Additionally two embolized ivc filter struts were located within the right ventricle.The detached strut retained in right ventricle free wall and the apex of the right ventricle septum were removed via an open chest procedure after an unsuccessful open chest procedure.The patient suffers from fissure on sternum due to the open chest removal surgery.The current status of the patient is unknown.
 
Manufacturer Narrative
H10: manufacturing review: a lot history review was performed.This is the only complaint to date for this lot number.Therefore, a device history record review is not required.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately five years and four months post deployment, a computed tomography of chest showed that there were two curvilinear radiopaque opacities within the right ventricle.These were compatible with embolized fractured inferior vena cava filter struts.A computed tomography of abdomen and pelvis was also performed in the same day which there were fractured struts extended superiorly and leftward and appeared to be localized within the inferior vena cava lumen.The study also showed that a total of nine additional struts extended inferiorly from the filter apex and several of these struts demonstrated penetration beyond the lumen of the inferior vena cava, including struts abutted the undersurface of the duodenum, the lateral aspect of the aorta, and the anterior aspect of the vertebral bodies.The next day, through the right internal jugular vein approach, the filter was removed.The cavogram study showed the filter was fractured with one locally retained arm in the inferior vena cava and two arms in the right ventricle.The filter was then dissected free of the wall of the inferior vena cava using endobronchial forceps in the jaws of life technique and was removed successfully.Next the locally retained fragment was also removed using forceps.Post removal cavogram was performed which showed successful complex filter removal.A ventriculogram demonstrated two filter struts in the anteroinferior right ventricle and the septal fragment appeared to be fully encapsulated in tissue.Multiple unsuccessful attempts were made to remove the foreign bodies with snares.One of the two fragments of the filler could be palpated in the right ventricle.This was visually identified and extracted from the wall of the right ventricle, where it was deeply imbedded.The other fragment could not be identified.Around five days later, a computed tomography of chest showed a curvilinear radiopaque opacity near the right ventricular apex, in keeping with an embolized fractured filter strut.Two days later, computed tomography of chest showed that there was an approximately 3.5cm linear metallic density at the apex of the right ventricle.Therefore, the investigation is confirmed for filter limb detachment, perforation of inferior vena cava and retrieval difficulties.Per medical records, multiple attempts were made to engage the apex of the filter but were unsuccessful due to filter limb detachment and perforation of inferior vena cava.This could have contributed to the retrieval difficulties.However, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.H10: b2, b6, b7, d4(expiry date: 05/2013), g3, h6(patient, method, conclusion).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MERIDIAN FILTER SYSTEM ¿ FEMORAL
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key9932531
MDR Text Key186732773
Report Number2020394-2020-02445
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K112497
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 03/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberMD800F
Device Lot NumberGFWC3808
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/19/2020
Initial Date FDA Received04/07/2020
Supplement Dates Manufacturer Received05/29/2020
02/08/2022
Supplement Dates FDA Received06/25/2020
03/09/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CALCIUM, CELEBREX, CLARITIN; GLUCOSAMINE CHONDROITIN, HYZAAR, VITAMIN B12; GUAIFENESIN, CLOBETASOL PROPIONATE, MELOXICAM; LOSARTAN HYDROCHLOROTHIAZIDE, FLEXERIL AND MUCINEX; VITAMIN C, VITAMIN D2, CYCLOBENZAPRINE
Patient Outcome(s) Required Intervention; Other;
Patient Age67 YR
Patient SexFemale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-